261 related articles for article (PubMed ID: 26589884)
1. Interaction of natural killer cells with neutrophils exerts a significant antitumor immunity in hematopoietic stem cell transplantation recipients.
Ueda R; Narumi K; Hashimoto H; Miyakawa R; Okusaka T; Aoki K
Cancer Med; 2016 Jan; 5(1):49-60. PubMed ID: 26589884
[TBL] [Abstract][Full Text] [Related]
2. Human NK cells: From surface receptors to clinical applications.
Moretta L; Pietra G; Vacca P; Pende D; Moretta F; Bertaina A; Mingari MC; Locatelli F; Moretta A
Immunol Lett; 2016 Oct; 178():15-9. PubMed ID: 27185471
[TBL] [Abstract][Full Text] [Related]
3. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
Ghiringhelli F; Ménard C; Terme M; Flament C; Taieb J; Chaput N; Puig PE; Novault S; Escudier B; Vivier E; Lecesne A; Robert C; Blay JY; Bernard J; Caillat-Zucman S; Freitas A; Tursz T; Wagner-Ballon O; Capron C; Vainchencker W; Martin F; Zitvogel L
J Exp Med; 2005 Oct; 202(8):1075-85. PubMed ID: 16230475
[TBL] [Abstract][Full Text] [Related]
4. Preimmunization of donor lymphocytes enhances antitumor immunity of autologous hematopoietic stem cell transplantation.
Suzuki K; Aida K; Miyakawa R; Narumi K; Udagawa T; Yoshida T; Ohshima Y; Aoki K
Cancer Med; 2013 Oct; 2(5):636-45. PubMed ID: 24403229
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic MHC gene transfer enhances an effective antitumor immunity in the early period of autologous hematopoietic stem cell transplantation.
Kobayashi A; Hara H; Ohashi M; Nishimoto T; Yoshida K; Ohkohchi N; Yoshida T; Aoki K
Clin Cancer Res; 2007 Dec; 13(24):7469-79. PubMed ID: 18094431
[TBL] [Abstract][Full Text] [Related]
6. Improved Antitumor Effect of NK Cells Activated by Neutrophils in a Bone Marrow Transplant Model.
Nakato D; Iwamoto S; Amano K; Ito T; Toyoda H; Hanaki R; Morimoto M; Niwa K; Tawara I; Imanaka-Yoshida K; Ogawa M; Hirayama M
Mediators Inflamm; 2023; 2023():6316581. PubMed ID: 36762286
[TBL] [Abstract][Full Text] [Related]
7. NK Cell-Mediated Antitumor Effects of a Folate-Conjugated Immunoglobulin Are Enhanced by Cytokines.
Jaime-Ramirez AC; McMichael E; Kondadasula S; Skinner CC; Mundy-Bosse BL; Luedke E; Jones NB; Mani A; Roda J; Karpa V; Li H; Li J; Elavazhagan S; La Perle KM; Schmitt AC; Lu Y; Zhang X; Pan X; Mao H; Davis M; Jarjoura D; Butchar JP; Poi M; Phelps M; Tridandapani S; Byrd JC; Caligiuri MA; Lee RJ; Carson WE
Cancer Immunol Res; 2016 Apr; 4(4):323-336. PubMed ID: 26865456
[TBL] [Abstract][Full Text] [Related]
8. NK cell adoptive transfer combined with Ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses.
Salagianni M; Lekka E; Moustaki A; Iliopoulou EG; Baxevanis CN; Papamichail M; Perez SA
J Immunol; 2011 Mar; 186(6):3327-35. PubMed ID: 21317394
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor-D-mediated blockade of regulatory T cells within tumors is induced by hematopoietic stem cell transplantation.
Udagawa T; Narumi K; Suzuki K; Aida K; Miyakawa R; Ikarashi Y; Makimoto A; Chikaraishi T; Yoshida T; Aoki K
J Immunol; 2013 Sep; 191(6):3440-52. PubMed ID: 23966628
[TBL] [Abstract][Full Text] [Related]
10. Negative depletion of α/β+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation.
Locatelli F; Bauquet A; Palumbo G; Moretta F; Bertaina A
Immunol Lett; 2013; 155(1-2):21-3. PubMed ID: 24091162
[TBL] [Abstract][Full Text] [Related]
11. A novel method to quantify and characterize leukemia-reactive natural killer cells in patients undergoing allogeneic hematopoietic stem cell transplantation following conventional or reduced-dose conditioning.
Penack O; Fischer L; Stroux A; Gentilini C; Nogai A; Muessig A; Ganepola S; Lange T; Kliem C; Marinets O; Blau IW; Thiel E; Uhareka L
Int J Hematol; 2007 May; 85(4):326-32. PubMed ID: 17483077
[TBL] [Abstract][Full Text] [Related]
12. Pre-immunization of donor lymphocytes with GITR agonistic antibody enhances antitumor immunity in autologous hematopoietic stem cell transplantation.
Henmi M; Shibasaki C; Mizoguchi Y; Hirata A; Sawai E; Narumi K; Aoki K
Biochem Biophys Res Commun; 2019 Jan; 509(1):96-101. PubMed ID: 30579597
[TBL] [Abstract][Full Text] [Related]
13. Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.
Kim SY; Lee H; Han MS; Shim H; Eom HS; Park B; Kong SY
Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):527-535.e2. PubMed ID: 27375156
[TBL] [Abstract][Full Text] [Related]
14. Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies.
Zaghi E; Calvi M; Di Vito C; Mavilio D
Front Immunol; 2019; 10():2794. PubMed ID: 31849972
[TBL] [Abstract][Full Text] [Related]
15. NK cells are the crucial antitumor mediators when STAT3-mediated immunosuppression is blocked in hepatocellular carcinoma.
Sui Q; Zhang J; Sun X; Zhang C; Han Q; Tian Z
J Immunol; 2014 Aug; 193(4):2016-23. PubMed ID: 25015826
[TBL] [Abstract][Full Text] [Related]
16. Cancer cell-binding peptide fused Fc domain activates immune effector cells and blocks tumor growth.
Mobergslien A; Peng Q; Vasovic V; Sioud M
Oncotarget; 2016 Nov; 7(46):75940-75953. PubMed ID: 27713158
[TBL] [Abstract][Full Text] [Related]
17. The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression.
Ghiringhelli F; Ménard C; Martin F; Zitvogel L
Immunol Rev; 2006 Dec; 214():229-38. PubMed ID: 17100888
[TBL] [Abstract][Full Text] [Related]
18. NK Cell Functional Impairment after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Reduced Levels of T-bet and Eomesodermin.
Simonetta F; Pradier A; Bosshard C; Masouridi-Levrat S; Chalandon Y; Roosnek E
J Immunol; 2015 Nov; 195(10):4712-20. PubMed ID: 26438526
[TBL] [Abstract][Full Text] [Related]
19. Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice.
Newman RG; Dee MJ; Malek TR; Podack ER; Levy RB
Blood; 2014 May; 123(19):3045-55. PubMed ID: 24687086
[TBL] [Abstract][Full Text] [Related]
20. NK cells specifically TCR-dressed to kill cancer cells.
Mensali N; Dillard P; Hebeisen M; Lorenz S; Theodossiou T; Myhre MR; Fåne A; Gaudernack G; Kvalheim G; Myklebust JH; Inderberg EM; Wälchli S
EBioMedicine; 2019 Feb; 40():106-117. PubMed ID: 30665853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
